This week, FDA advisory committee unanimously recommends Moderna booster shot; the USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older; FDA permits marketing of new e-cigarette products; and more.
Read the full coverage here:
FDA advisory committee unanimously recommends Moderna booster shot
USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older
FDA permits marketing of new e-cigarette products, marking first authorization of its kind
More than half of COVID-19 survivors experience symptoms 6 months after recovery
FDA issues new guidance on sodium, calls it ‘pivotal’ moment in US health
References:
Groff D, et al. JAMA Network Open. 2021;doi:10.1001/jamanetworkopen.2021.28568.
FDA Conference Call
